Background illustration for clinical trials search

Paid Clinical Trials Tacoma

Discover 1,461 paid clinical trials in Tacoma, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

for
HIV Infections
Location: Seattle WA, Bakersfield CA, West Hollywood CA,
Sponsor: ViiV Healthcare

Sex: All

Age: 18+

Code: NCT07202546

Phase 2, Recruiting

Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).

for
Higher-risk Myelodysplastic Syndrome
Location: Issaquah WA, Seattle WA, Edmonds WA, Eugene OR,
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT06641414

Phase 3, Recruiting

Study of Olverembatinib (HQP1351) in Patients With CML-CP

for
Chronic Myeloid Leukemia, CML, CML, Chronic Phase
Location: Seattle WA, Issaquah WA, Edmonds WA, Reno NV,
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT06423911

Phase 3, Recruiting
New

Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer

for
Colon Cancer
Location: Seattle WA, Los Angeles CA, Cleveland OH
Sponsor: Solstice Oncology, Inc.

Sex: All

Age: 18+

Code: NCT07808151

Phase 2, Recruiting

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Seattle WA, Portland OR, San Francisco CA,
Sponsor: Dianthus Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06858579

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

for
Relapsed/Refractory Multiple Myeloma
Location: Seattle WA, Edmonds WA, San Francisco CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05850234

Phase 1, Phase 2, Recruiting

Role of CYP2B6, CYP3A4, and MDR1 in the Metabolic Clearance of Methadone

for
Substance-Related Disorders
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18 - 40

Code: NCT00504413

Phase 1, Recruiting

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer
Location: Seattle WA, Edmonds WA, Los Angeles CA, Winnipeg,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT05061550

Phase 2, Recruiting

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

for
B-cell Malignancies
Location: Seattle WA, Calgary, La Jolla CA, Rochester MN,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06542250

Phase 1, Phase 2, Recruiting

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

for
Transthyretin Amyloidosis, ATTR-CM, ATTRv-PN, ATTR, ATTR-Mixed,
Location: Seattle WA, Portland OR, Vancouver, San Francisco CA,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06465810

Recruiting

SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects

for
Cystic Fibrosis
Location: Seattle WA, Spokane WA, Salt Lake City UT,
Sponsor: Aridis Pharmaceuticals, Inc.

Sex: All

Age: 18 - 49

Code: NCT03669614

Phase 1, Phase 2, Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

for
Non-Small Cell Lung Cancer
Location: Seattle WA, Vancouver WA, Portland OR, Eugene OR,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT06767514

Phase 3, Recruiting

Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis

for
Endometriosis
Location: Seattle WA, Columbus OH, Norfolk VA, Sarasota FL
Sponsor: Enteris BioPharma Inc.

Sex: Female

Age: 18 - 49

Code: NCT05096065

Phase 2, Recruiting

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old

for
Congenital Adrenal Hyperplasia
Location: Seattle WA, Aurora CO, San Francisco CA,
Sponsor: Neurocrine Switzerland GmbH

Sex: All

Age: 0 - 3

Code: NCT07536269

Phase 2, Recruiting

A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)

for
Human Papilloma Virus (HPV),
Location: Seattle WA, Layton UT, Phoenix AZ, Tucson AZ,
Sponsor: Daré Bioscience, Inc.

Sex: Female

Age: 22 - 50

Code: NCT07601074

Phase 2, Recruiting

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

for
Migraine
Location: Seattle WA, Portland OR, Reno NV, Walnut Creek CA,
Sponsor: TriGemX Bio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07645924

Phase 3, Recruiting

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

for
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma,
Location: Seattle WA, Issaquah WA, Edmonds WA, Portland OR,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07431281

Phase 3, Recruiting

An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

for
Multiple Sclerosis
Location: Seattle WA, Milwaukee WI, St Louis MO,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 60

Code: NCT07224373

Phase 1, Recruiting

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

for
Epithelial Ovarian Cancer
Location: Seattle WA, Portland OR, Billings MT, Las Vegas NV,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT07218809

Phase 3, Recruiting

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

for
Acute Migraine
Location: Seattle WA, Portland OR, Reno NV, Walnut Creek CA,
Sponsor: TriGemX Bio, Inc.

Sex: All

Age: 18+

Code: NCT07674654

Phase 3, Recruiting